HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minkyu Hur Selected Research

1,4-diphenyl-2-mercaptoimidazole

12/2009Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minkyu Hur Research Topics

Disease

4Neoplasms (Cancer)
10/2020 - 02/2016
2Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 02/2016
1Glioblastoma (Glioblastoma Multiforme)
10/2020
1Stomach Neoplasms (Stomach Cancer)
01/2019
1Autoimmune Diseases (Autoimmune Disease)
12/2009
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2009
1Hypersensitivity (Allergy)
12/2009

Drug/Important Bio-Agent (IBA)

4GC1118IBA
10/2020 - 02/2016
4Cetuximab (Erbitux)FDA Link
10/2020 - 02/2016
3Monoclonal AntibodiesIBA
10/2020 - 02/2016
2ErbB Receptors (EGF Receptor)IBA
10/2020 - 11/2019
1Biomarkers (Surrogate Marker)IBA
10/2020
1TOR Serine-Threonine KinasesIBA
11/2019
1Panitumumab (Vectibix)FDA Link
11/2019
1LigandsIBA
02/2016
11,4-diphenyl-2-mercaptoimidazoleIBA
12/2009
1Bovine Serum AlbuminIBA
12/2009

Therapy/Procedure

1Therapeutics
02/2016
1Oral Administration
12/2009